Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16908138rdf:typepubmed:Citationlld:pubmed
pubmed-article:16908138lifeskim:mentionsumls-concept:C0220847lld:lifeskim
pubmed-article:16908138lifeskim:mentionsumls-concept:C0178539lld:lifeskim
pubmed-article:16908138lifeskim:mentionsumls-concept:C0184511lld:lifeskim
pubmed-article:16908138lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:16908138lifeskim:mentionsumls-concept:C0035142lld:lifeskim
pubmed-article:16908138lifeskim:mentionsumls-concept:C1335439lld:lifeskim
pubmed-article:16908138lifeskim:mentionsumls-concept:C0021236lld:lifeskim
pubmed-article:16908138lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:16908138lifeskim:mentionsumls-concept:C0053183lld:lifeskim
pubmed-article:16908138pubmed:issue19lld:pubmed
pubmed-article:16908138pubmed:dateCreated2006-8-25lld:pubmed
pubmed-article:16908138pubmed:abstractTextBenzimidazole-based allosteric inhibitors of the hepatitis C virus (HCV) NS5B polymerase were diversified to a variety of topologically related scaffolds. Replacement of the polar benzimidazole core by lipophilic indoles led to inhibitors with improved potency in the cell-based subgenomic HCV replicon system. Transposing the indole scaffold into a previously described series of benzimidazole-tryptophan amides generated the most potent inhibitors of HCV RNA replication in cell culture reported to date in this series (EC(50) approximately 50 nM).lld:pubmed
pubmed-article:16908138pubmed:languageenglld:pubmed
pubmed-article:16908138pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16908138pubmed:citationSubsetIMlld:pubmed
pubmed-article:16908138pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16908138pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16908138pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16908138pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16908138pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16908138pubmed:statusMEDLINElld:pubmed
pubmed-article:16908138pubmed:monthOctlld:pubmed
pubmed-article:16908138pubmed:issn0960-894Xlld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:ThauvetteLoui...lld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:BykowskiDarre...lld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:McKercherGine...lld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:KukoljGeorgeGlld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:JakalianArazAlld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:LagacéLisette...lld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:BrochuChristi...lld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:DansereauNath...lld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:HachéBrunoBlld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:BeaulieuPierr...lld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:GillardJamesJlld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:LaPlanteSteve...lld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:DuceppeJean-S...lld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:MoreauElaineElld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:PerreaultStép...lld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:StammersTimot...lld:pubmed
pubmed-article:16908138pubmed:authorpubmed-author:WarringtonJef...lld:pubmed
pubmed-article:16908138pubmed:issnTypePrintlld:pubmed
pubmed-article:16908138pubmed:day1lld:pubmed
pubmed-article:16908138pubmed:volume16lld:pubmed
pubmed-article:16908138pubmed:ownerNLMlld:pubmed
pubmed-article:16908138pubmed:authorsCompleteYlld:pubmed
pubmed-article:16908138pubmed:pagination4987-93lld:pubmed
pubmed-article:16908138pubmed:meshHeadingpubmed-meshheading:16908138...lld:pubmed
pubmed-article:16908138pubmed:meshHeadingpubmed-meshheading:16908138...lld:pubmed
pubmed-article:16908138pubmed:meshHeadingpubmed-meshheading:16908138...lld:pubmed
pubmed-article:16908138pubmed:meshHeadingpubmed-meshheading:16908138...lld:pubmed
pubmed-article:16908138pubmed:meshHeadingpubmed-meshheading:16908138...lld:pubmed
pubmed-article:16908138pubmed:meshHeadingpubmed-meshheading:16908138...lld:pubmed
pubmed-article:16908138pubmed:meshHeadingpubmed-meshheading:16908138...lld:pubmed
pubmed-article:16908138pubmed:meshHeadingpubmed-meshheading:16908138...lld:pubmed
pubmed-article:16908138pubmed:meshHeadingpubmed-meshheading:16908138...lld:pubmed
pubmed-article:16908138pubmed:meshHeadingpubmed-meshheading:16908138...lld:pubmed
pubmed-article:16908138pubmed:meshHeadingpubmed-meshheading:16908138...lld:pubmed
pubmed-article:16908138pubmed:year2006lld:pubmed
pubmed-article:16908138pubmed:articleTitleImproved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: from benzimidazole to indole scaffolds.lld:pubmed
pubmed-article:16908138pubmed:affiliationBoehringer Ingelheim, Canada, Ltd., Research and Development, 2100 Cunard Street, Laval, Québec, Canada H7S 2G5. pbeaulieu@lav.boehringer-ingelheim.comlld:pubmed
pubmed-article:16908138pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:16908138lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16908138lld:pubmed